ANTIPHONICS IVS: Financial statements 2018
CVR: 35651543
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
ANTIPHONICS IVS (CVR 35651543) has filed annual accounts for 2018. In 2018, the company reported revenue of DKK 69,850 and a net result of DKK 36,009 compared with DKK 9,340 the year before. That is an increase of 70.2% compared with the year before. The profit margin was 51.6%. Equity in the 2018 report amounted to DKK 13,100. The solvency ratio was 93.6%.
- Revenue
- DKK 69,850
- Gross Profit
- DKK 44,781
- Profit/Loss
- DKK 36,009
- Equity
- DKK 13,100
- Total Assets
- DKK 14,002
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | 70 t. | 45 t. | 36 t. | 13 t. | - |
| 2017 | 41 t. | 14 t. | 9 t. | 24 t. | - |
| 2016 | 45 t. | 21 t. | 16 t. | 40 t. | - |
| 2015 | 75 t. | 22 t. | -6 t. | 63 t. | - |
| 2014 | 34 t. | -39 t. | -57 t. | 57 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
ANTIPHONICS IVS has published its annual report for 2017. Revenue came to DKK 41,040, and the net result was DKK 9,340.
About ANTIPHONICS IVS
ANTIPHONICS IVS was a Danish company of the type Iværksætterselskab based in Herlev, founded in 2014. The company has been dissolved on 2 December 2021. The company was registered under the industry Indspilning af lydoptagelser og udgivelse af musik. In 2020, the company reported revenue of DKK 11,726 and a net result of DKK -7,946 compared with DKK -6,694 the year before. Equity in the 2020 report amounted to DKK 122,533.